Eosinophil-rich tissue infiltrates in chronic myelomonocytic leukemia patients

Abstract Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic disorder that associates dysplastic and proliferative features. Tissue inflammatory disorders occur in a fraction of CMML patients during the course of their disease. Here, we describe the occurrence of eosinophil-rich tissue inflammation, including eosinophilic pneumonia, chondritis, and cystitis, in CMML patients. Whole exome sequencing of leukemic cells did not identify a recurrent genetic abnormality among these three patients who were clinically improved by local or oral corticosteroids. Hypomethylating drugs were subsequently added in two of them, allowing decreasing corticosteroid doses and further treating their hematopoietic malignancy.

[1]  M. Cazzola,et al.  Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia. , 2016, Blood.

[2]  A. Tefferi,et al.  Chronic myelomonocytic leukemia: 2016 update on diagnosis, risk stratification, and management , 2016, American journal of hematology.

[3]  Mario Cazzola,et al.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.

[4]  M. Stratton,et al.  Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents , 2016, Nature Communications.

[5]  J. Piette,et al.  Systemic inflammatory and autoimmune manifestations associated with myelodysplastic syndromes and chronic myelomonocytic leukaemia: a French multicentre retrospective study. , 2016, Rheumatology.

[6]  L. Medeiros,et al.  Hematolymphoid neoplasms associated with rearrangements of PDGFRA, PDGFRB, and FGFR1. , 2015, American journal of clinical pathology.

[7]  F. Oliva,et al.  Eosinophilic myocarditis: a paraneoplastic event , 2015, The Lancet.

[8]  E. Solary,et al.  Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia. , 2015, Blood.

[9]  Gang Li,et al.  Clinical and radiological character of eosinophilic cystitis. , 2015, International journal of clinical and experimental medicine.

[10]  G. Garcia-Manero,et al.  Discovery of imatinib-responsive FIP1L1-PDGFRA mutation during refractory acute myeloid leukemia transformation of chronic myelomonocytic leukemia , 2014, Journal of Hematology & Oncology.

[11]  A. Nakashima,et al.  A positive role of mammalian Tip41‐like protein, TIPRL, in the amino‐acid dependent mTORC1‐signaling pathway through interaction with PP2A , 2013, FEBS letters.

[12]  D. Birnbaum,et al.  Prognostic score including gene mutations in chronic myelomonocytic leukemia. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  E. Solary,et al.  Clonal architecture of chronic myelomonocytic leukemias. , 2013, Blood.

[14]  P. A. Futreal,et al.  Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma , 2010, Nature.

[15]  A. Wardlaw,et al.  Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tract. , 2010, The Journal of allergy and clinical immunology.

[16]  J. Kushner,et al.  Identification of a WD40 Repeat-Containing Isoform of PHIP as a Novel Regulator of β-Cell Growth and Survival , 2007, Molecular and Cellular Biology.

[17]  B. Cheson,et al.  Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. , 2006, Blood.

[18]  W. Saliba,et al.  Eosinophilic pancreatic infiltration as a manifestation of lung carcinoma. , 2006, The American journal of the medical sciences.